APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lyophilized IVIG

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lyophilized IVIG Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchLyophilized IVIG Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyophilized IVIG Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Lyophilized IVIG Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyophilized IVIG Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyophilized IVIG Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lyophilized IVIG market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lyophilized IVIG include Biotest, BPL, CBPO, CNBG, CSL, Grifols, Kedrion, LFB Group and Octapharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lyophilized IVIG market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lyophilized IVIG and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lyophilized IVIG sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lyophilized IVIG market size, projected growth trends, production technologies, key applications, and end-use industries.

Lyophilized IVIG Segment by Company

Biotest

BPL

CBPO

CNBG

CSL

Grifols

Kedrion

LFB Group

Octapharma

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

Takeda

Lyophilized IVIG Segment by Type

2.5g

1.25g

Lyophilized IVIG Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Lyophilized IVIG Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyophilized IVIG market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyophilized IVIG and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyophilized IVIG.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lyophilized IVIG market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lyophilized IVIG Industry Trends Table 2. Lyophilized IVIG Industry Drivers Table 3. Lyophilized IVIG Industry Opportunities and Challenges Table 4. Lyophilized IVIG Industry Restraints Table 5. Global Lyophilized IVIG Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lyophilized IVIG Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lyophilized IVIG Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Lyophilized IVIG Sales Market Share by Manufacturers Table 9. Global Lyophilized IVIG Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Lyophilized IVIG Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lyophilized IVIG Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lyophilized IVIG Manufacturers, Product Type & Application Table 13. Global Lyophilized IVIG Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lyophilized IVIG by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2.5g Table 17. Major Manufacturers of 1.25g Table 18. Global Lyophilized IVIG Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Lyophilized IVIG Sales by Type (2021-2026) & (k units) Table 20. Global Lyophilized IVIG Sales by Type (2027-2032) & (k units) Table 21. Global Lyophilized IVIG Sales Market Share by Type (2021-2026) Table 22. Global Lyophilized IVIG Sales Market Share by Type (2027-2032) Table 23. Global Lyophilized IVIG Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Lyophilized IVIG Revenue by Type (2021-2026) & (k units) Table 25. Global Lyophilized IVIG Revenue by Type (2027-2032) & (k units) Table 26. Global Lyophilized IVIG Revenue Market Share by Type (2021-2026) Table 27. Global Lyophilized IVIG Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Autoimmune Disease Table 29. Major Manufacturers of Immunodeficiency Table 30. Major Manufacturers of Acute Infection Table 31. Global Lyophilized IVIG Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Lyophilized IVIG Sales by Application (2021-2026) & (k units) Table 33. Global Lyophilized IVIG Sales by Application (2027-2032) & (k units) Table 34. Global Lyophilized IVIG Sales Market Share by Application (2021-2026) Table 35. Global Lyophilized IVIG Sales Market Share by Application (2027-2032) Table 36. Global Lyophilized IVIG Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Lyophilized IVIG Revenue by Application (2021-2026) & (k units) Table 38. Global Lyophilized IVIG Revenue by Application (2027-2032) & (k units) Table 39. Global Lyophilized IVIG Revenue Market Share by Application (2021-2026) Table 40. Global Lyophilized IVIG Revenue Market Share by Application (2027-2032) Table 41. Global Lyophilized IVIG Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Lyophilized IVIG Sales by Region (2021-2026) & (k units) Table 43. Global Lyophilized IVIG Sales Market Share by Region (2021-2026) Table 44. Global Lyophilized IVIG Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Lyophilized IVIG Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 48. North America Lyophilized IVIG Sales by Country (2027-2032) & (k units) Table 49. Europe Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 51. Europe Lyophilized IVIG Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Lyophilized IVIG Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Lyophilized IVIG Sales by Country (2027-2032) & (k units) Table 58. Global Lyophilized IVIG Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lyophilized IVIG Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lyophilized IVIG Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lyophilized IVIG Revenue Market Share by Region (2021-2026) Table 62. Global Lyophilized IVIG Revenue Market Share by Region (2027-2032) Table 63. Biotest Company Information Table 64. Biotest Business Overview Table 65. Biotest Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Biotest Lyophilized IVIG Product Portfolio Table 67. Biotest Recent Development Table 68. BPL Company Information Table 69. BPL Business Overview Table 70. BPL Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BPL Lyophilized IVIG Product Portfolio Table 72. BPL Recent Development Table 73. CBPO Company Information Table 74. CBPO Business Overview Table 75. CBPO Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CBPO Lyophilized IVIG Product Portfolio Table 77. CBPO Recent Development Table 78. CNBG Company Information Table 79. CNBG Business Overview Table 80. CNBG Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CNBG Lyophilized IVIG Product Portfolio Table 82. CNBG Recent Development Table 83. CSL Company Information Table 84. CSL Business Overview Table 85. CSL Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CSL Lyophilized IVIG Product Portfolio Table 87. CSL Recent Development Table 88. Grifols Company Information Table 89. Grifols Business Overview Table 90. Grifols Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Grifols Lyophilized IVIG Product Portfolio Table 92. Grifols Recent Development Table 93. Kedrion Company Information Table 94. Kedrion Business Overview Table 95. Kedrion Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kedrion Lyophilized IVIG Product Portfolio Table 97. Kedrion Recent Development Table 98. LFB Group Company Information Table 99. LFB Group Business Overview Table 100. LFB Group Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. LFB Group Lyophilized IVIG Product Portfolio Table 102. LFB Group Recent Development Table 103. Octapharma Company Information Table 104. Octapharma Business Overview Table 105. Octapharma Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Octapharma Lyophilized IVIG Product Portfolio Table 107. Octapharma Recent Development Table 108. Hualan Bio Company Information Table 109. Hualan Bio Business Overview Table 110. Hualan Bio Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hualan Bio Lyophilized IVIG Product Portfolio Table 112. Hualan Bio Recent Development Table 113. Shanghai RAAS Company Information Table 114. Shanghai RAAS Business Overview Table 115. Shanghai RAAS Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Shanghai RAAS Lyophilized IVIG Product Portfolio Table 117. Shanghai RAAS Recent Development Table 118. Sichuan Yuanda Shuyang Company Information Table 119. Sichuan Yuanda Shuyang Business Overview Table 120. Sichuan Yuanda Shuyang Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio Table 122. Sichuan Yuanda Shuyang Recent Development Table 123. Takeda Company Information Table 124. Takeda Business Overview Table 125. Takeda Lyophilized IVIG Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Takeda Lyophilized IVIG Product Portfolio Table 127. Takeda Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Lyophilized IVIG Distributors List Table 131. Lyophilized IVIG Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Lyophilized IVIG Product Image Figure 2. Global Lyophilized IVIG Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lyophilized IVIG Market Size (2021-2032) & (US$ Million) Figure 4. Global Lyophilized IVIG Sales (2021-2032) & (k units) Figure 5. Global Lyophilized IVIG Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lyophilized IVIG Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2.5g Image Figure 9. 1.25g Image Figure 10. Global Lyophilized IVIG Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Lyophilized IVIG Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lyophilized IVIG Sales Market Share by Type (2021-2032) Figure 13. Global Lyophilized IVIG Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Lyophilized IVIG Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lyophilized IVIG Revenue Market Share by Type (2021-2032) Figure 16. Autoimmune Disease Image Figure 17. Immunodeficiency Image Figure 18. Acute Infection Image Figure 19. Global Lyophilized IVIG Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Lyophilized IVIG Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lyophilized IVIG Sales Market Share by Application (2021-2032) Figure 22. Global Lyophilized IVIG Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Lyophilized IVIG Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lyophilized IVIG Revenue Market Share by Application (2021-2032) Figure 25. North America Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Lyophilized IVIG Sales Market Share by Country (2021-2032) Figure 27. U.S. Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Lyophilized IVIG Sales Market Share by Country (2021-2032) Figure 32. Germany Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Lyophilized IVIG Sales Market Share by Country (2021-2032) Figure 39. China Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Lyophilized IVIG Sales Market Share by Country (2021-2032) Figure 47. Brazil Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Lyophilized IVIG Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Lyophilized IVIG Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lyophilized IVIG Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lyophilized IVIG Revenue (2021-2032) & (US$ Million) Figure 58. North America Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lyophilized IVIG Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lyophilized IVIG Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lyophilized IVIG Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lyophilized IVIG Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lyophilized IVIG Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5g
  • 1.25g
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Biotest
  • BPL
  • CBPO
  • CNBG
  • CSL
  • Grifols
  • Kedrion
  • LFB Group
  • Octapharma
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lyophilized IVIG Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lyophilized IVIG Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lyophilized IVIG Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lyophilized IVIG Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lyophilized IVIG Market Dynamics
  1. 2.1 Lyophilized IVIG Industry Trends
  2. 2.2 Lyophilized IVIG Industry Drivers
  3. 2.3 Lyophilized IVIG Industry Opportunities and Challenges
  4. 2.4 Lyophilized IVIG Industry Restraints
3 Lyophilized IVIG Market by Manufacturers
  1. 3.1 Global Lyophilized IVIG Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lyophilized IVIG Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lyophilized IVIG Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lyophilized IVIG Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lyophilized IVIG Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lyophilized IVIG Manufacturers, Product Type & Application
  7. 3.7 Global Lyophilized IVIG Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lyophilized IVIG Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lyophilized IVIG Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lyophilized IVIG Tier 1, Tier 2, and Tier 3
4 Lyophilized IVIG Market by Type
  1. 4.1 Lyophilized IVIG Type Introduction
  2. 4.1.1 2.5g
  3. 4.1.2 1.25g
  4. 4.2 Global Lyophilized IVIG Sales by Type
  5. 4.2.1 Global Lyophilized IVIG Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lyophilized IVIG Sales by Type (2021-2032)
  7. 4.2.3 Global Lyophilized IVIG Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lyophilized IVIG Revenue by Type
  9. 4.3.1 Global Lyophilized IVIG Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lyophilized IVIG Revenue by Type (2021-2032)
  11. 4.3.3 Global Lyophilized IVIG Revenue Market Share by Type (2021-2032)
5 Lyophilized IVIG Market by Application
  1. 5.1 Lyophilized IVIG Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Lyophilized IVIG Sales by Application
  6. 5.2.1 Global Lyophilized IVIG Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lyophilized IVIG Sales by Application (2021-2032)
  8. 5.2.3 Global Lyophilized IVIG Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lyophilized IVIG Revenue by Application
  10. 5.3.1 Global Lyophilized IVIG Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lyophilized IVIG Revenue by Application (2021-2032)
  12. 5.3.3 Global Lyophilized IVIG Revenue Market Share by Application (2021-2032)
6 Global Lyophilized IVIG Sales by Region
  1. 6.1 Global Lyophilized IVIG Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lyophilized IVIG Sales by Region (2021-2032)
  3. 6.2.1 Global Lyophilized IVIG Sales by Region (2021-2026)
  4. 6.2.2 Global Lyophilized IVIG Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lyophilized IVIG Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lyophilized IVIG Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lyophilized IVIG Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lyophilized IVIG Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lyophilized IVIG Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lyophilized IVIG Revenue by Region
  1. 7.1 Global Lyophilized IVIG Revenue by Region
  2. 7.1.1 Global Lyophilized IVIG Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lyophilized IVIG Revenue by Region (2021-2026)
  4. 7.1.3 Global Lyophilized IVIG Revenue by Region (2027-2032)
  5. 7.1.4 Global Lyophilized IVIG Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lyophilized IVIG Revenue (2021-2032)
  8. 7.2.2 North America Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lyophilized IVIG Revenue (2021-2032)
  11. 7.3.2 Europe Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lyophilized IVIG Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lyophilized IVIG Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lyophilized IVIG Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biotest
  2. 8.1.1 Biotest Company Information
  3. 8.1.2 Biotest Business Overview
  4. 8.1.3 Biotest Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biotest Lyophilized IVIG Product Portfolio
  6. 8.1.5 Biotest Recent Developments
  7. 8.2 BPL
  8. 8.2.1 BPL Company Information
  9. 8.2.2 BPL Business Overview
  10. 8.2.3 BPL Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BPL Lyophilized IVIG Product Portfolio
  12. 8.2.5 BPL Recent Developments
  13. 8.3 CBPO
  14. 8.3.1 CBPO Company Information
  15. 8.3.2 CBPO Business Overview
  16. 8.3.3 CBPO Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CBPO Lyophilized IVIG Product Portfolio
  18. 8.3.5 CBPO Recent Developments
  19. 8.4 CNBG
  20. 8.4.1 CNBG Company Information
  21. 8.4.2 CNBG Business Overview
  22. 8.4.3 CNBG Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CNBG Lyophilized IVIG Product Portfolio
  24. 8.4.5 CNBG Recent Developments
  25. 8.5 CSL
  26. 8.5.1 CSL Company Information
  27. 8.5.2 CSL Business Overview
  28. 8.5.3 CSL Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CSL Lyophilized IVIG Product Portfolio
  30. 8.5.5 CSL Recent Developments
  31. 8.6 Grifols
  32. 8.6.1 Grifols Company Information
  33. 8.6.2 Grifols Business Overview
  34. 8.6.3 Grifols Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Grifols Lyophilized IVIG Product Portfolio
  36. 8.6.5 Grifols Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion Lyophilized IVIG Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 LFB Group
  44. 8.8.1 LFB Group Company Information
  45. 8.8.2 LFB Group Business Overview
  46. 8.8.3 LFB Group Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LFB Group Lyophilized IVIG Product Portfolio
  48. 8.8.5 LFB Group Recent Developments
  49. 8.9 Octapharma
  50. 8.9.1 Octapharma Company Information
  51. 8.9.2 Octapharma Business Overview
  52. 8.9.3 Octapharma Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Octapharma Lyophilized IVIG Product Portfolio
  54. 8.9.5 Octapharma Recent Developments
  55. 8.10 Hualan Bio
  56. 8.10.1 Hualan Bio Company Information
  57. 8.10.2 Hualan Bio Business Overview
  58. 8.10.3 Hualan Bio Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Bio Lyophilized IVIG Product Portfolio
  60. 8.10.5 Hualan Bio Recent Developments
  61. 8.11 Shanghai RAAS
  62. 8.11.1 Shanghai RAAS Company Information
  63. 8.11.2 Shanghai RAAS Business Overview
  64. 8.11.3 Shanghai RAAS Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai RAAS Lyophilized IVIG Product Portfolio
  66. 8.11.5 Shanghai RAAS Recent Developments
  67. 8.12 Sichuan Yuanda Shuyang
  68. 8.12.1 Sichuan Yuanda Shuyang Company Information
  69. 8.12.2 Sichuan Yuanda Shuyang Business Overview
  70. 8.12.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio
  72. 8.12.5 Sichuan Yuanda Shuyang Recent Developments
  73. 8.13 Takeda
  74. 8.13.1 Takeda Company Information
  75. 8.13.2 Takeda Business Overview
  76. 8.13.3 Takeda Lyophilized IVIG Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Takeda Lyophilized IVIG Product Portfolio
  78. 8.13.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lyophilized IVIG Value Chain Analysis
  2. 9.1.1 Lyophilized IVIG Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lyophilized IVIG Production Mode & Process
  6. 9.2 Lyophilized IVIG Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lyophilized IVIG Distributors
  9. 9.2.3 Lyophilized IVIG Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst